» Articles » PMID: 30755531

Dynamically Stiffened Matrix Promotes Malignant Transformation of Mammary Epithelial Cells Via Collective Mechanical Signaling

Overview
Specialty Science
Date 2019 Feb 14
PMID 30755531
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer development is associated with increasing tissue stiffness over years. To more accurately mimic the onset of gradual matrix stiffening, which is not feasible with conventional static hydrogels, mammary epithelial cells (MECs) were cultured on methacrylated hyaluronic acid hydrogels whose stiffness can be dynamically modulated from "normal" (<150 Pascals) to "malignant" (>3,000 Pascals) via two-stage polymerization. MECs form and remain as spheroids, but begin to lose epithelial characteristics and gain mesenchymal morphology upon matrix stiffening. However, both the degree of matrix stiffening and culture time before stiffening play important roles in regulating this conversion as, in both cases, a subset of mammary spheroids remained insensitive to local matrix stiffness. This conversion depended neither on colony size nor cell density, and MECs did not exhibit "memory" of prior niche when serially cultured through cycles of compliant and stiff matrices. Instead, the transcription factor Twist1, transforming growth factor β (TGFβ), and YAP activation appeared to modulate stiffness-mediated signaling; when stiffness-mediated signals were blocked, collective MEC phenotypes were reduced in favor of single MECs migrating away from spheroids. These data indicate a more complex interplay of time-dependent stiffness signaling, spheroid structure, and soluble cues that regulates MEC plasticity than suggested by previous models.

Citing Articles

Full-thickness cervix reconstruction via collagen scaffolds in rabbits.

Li Y, Tian W, Guo J, Ye Y, Gao Q, Zhang Y Bioact Mater. 2025; 47:170-180.

PMID: 39906644 PMC: 11791012. DOI: 10.1016/j.bioactmat.2025.01.015.


Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer.

Zhang X, Al-Danakh A, Zhu X, Feng D, Yang L, Wu H Bioeng Transl Med. 2025; 10(1):e10698.

PMID: 39801760 PMC: 11711218. DOI: 10.1002/btm2.10698.


Targeting breast tumor extracellular matrix and stroma utilizing nanoparticles.

Muhammad F, Altalbawy F, Mandaliya V, Saraswat S, Rekha M, Aulakh D Clin Transl Oncol. 2024; .

PMID: 39692807 DOI: 10.1007/s12094-024-03793-x.


Epithelial-Mesenchymal Plasticity and Epigenetic Heterogeneity in Cancer.

Sacco J, Gomez E Cancers (Basel). 2024; 16(19).

PMID: 39409910 PMC: 11475326. DOI: 10.3390/cancers16193289.


Genetic variation drives cancer cell adaptation to ECM stiffness.

Wang T, Sawhney S, Morgan D, Bennett R, Rashmi R, Estecio M Proc Natl Acad Sci U S A. 2024; 121(39):e2403062121.

PMID: 39302966 PMC: 11441511. DOI: 10.1073/pnas.2403062121.


References
1.
Tse J, Engler A . Stiffness gradients mimicking in vivo tissue variation regulate mesenchymal stem cell fate. PLoS One. 2011; 6(1):e15978. PMC: 3016411. DOI: 10.1371/journal.pone.0015978. View

2.
Williams C, Engler A, Slone R, Galante L, Schwarzbauer J . Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res. 2008; 68(9):3185-92. PMC: 2748963. DOI: 10.1158/0008-5472.CAN-07-2673. View

3.
Kaushik G, Fuhrmann A, Cammarato A, Engler A . In situ mechanical analysis of myofibrillar perturbation and aging on soft, bilayered Drosophila myocardium. Biophys J. 2012; 101(11):2629-37. PMC: 3297788. DOI: 10.1016/j.bpj.2011.10.042. View

4.
Lo C, Wang H, Dembo M, Wang Y . Cell movement is guided by the rigidity of the substrate. Biophys J. 2000; 79(1):144-52. PMC: 1300921. DOI: 10.1016/S0006-3495(00)76279-5. View

5.
Kiang J, Wen J, Del Alamo J, Engler A . Dynamic and reversible surface topography influences cell morphology. J Biomed Mater Res A. 2013; 101(8):2313-21. PMC: 4433743. DOI: 10.1002/jbm.a.34543. View